APA

Groenemeijer B. E., Hallman M. D., Reymer P. W., Gagné E., Kuivenhoven J. A., Bruin T., Jansen H., Lie K. I., Bruschke A. V., Boerwinkle E., Hayden M. R. & Kastelein J. J. (19970717). Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. : Circulation.

Chicago

Groenemeijer B E, Hallman M D, Reymer P W, Gagné E, Kuivenhoven J A, Bruin T, Jansen H, Lie K I, Bruschke A V, Boerwinkle E, Hayden M R and Kastelein J J. 19970717. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. : Circulation.

Harvard

Groenemeijer B. E., Hallman M. D., Reymer P. W., Gagné E., Kuivenhoven J. A., Bruin T., Jansen H., Lie K. I., Bruschke A. V., Boerwinkle E., Hayden M. R. and Kastelein J. J. (19970717). Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. : Circulation.

MLA

Groenemeijer B E, Hallman M D, Reymer P W, Gagné E, Kuivenhoven J A, Bruin T, Jansen H, Lie K I, Bruschke A V, Boerwinkle E, Hayden M R and Kastelein J J. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. : Circulation. 19970717.